These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia. Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814 [TBL] [Abstract][Full Text] [Related]
27. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251 [TBL] [Abstract][Full Text] [Related]
29. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women. Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH Prenat Diagn; 2005 Nov; 25(11):1040-4. PubMed ID: 16231312 [TBL] [Abstract][Full Text] [Related]
30. Early detection of RhD status in pregnancies at risk of hemolytic disease of the newborn. Cotorruelo C; Biondi C; García Borrás S; Di Mónaco R; Racca A Clin Exp Med; 2002 Jul; 2(2):77-81. PubMed ID: 12141530 [TBL] [Abstract][Full Text] [Related]
31. Use of free fetal DNA in prenatal noninvasive detection of fetal RhD status and fetal gender by molecular analysis of maternal plasma. Sedrak M; Hashad D; Adel H; Azzam A; Elbeltagy N Genet Test Mol Biomarkers; 2011 Sep; 15(9):627-31. PubMed ID: 21488716 [TBL] [Abstract][Full Text] [Related]
32. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461 [TBL] [Abstract][Full Text] [Related]
35. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Gardener GJ; Legler TJ; Hyett JA; Liew YW; Flower RL; Hyland CA Transfusion; 2012 Sep; 52(9):2016-9. PubMed ID: 22313164 [TBL] [Abstract][Full Text] [Related]
36. Noninvasive fetal RHD genotyping by microfluidics digital PCR using maternal plasma from two alloimmunized women with the variant RHD(IVS3+1G>A) allele. Tsui NB; Hyland CA; Gardener GJ; Danon D; Fisk NM; Millard G; Flower RL; Lo YM Prenat Diagn; 2013 Dec; 33(12):1214-6. PubMed ID: 23999893 [No Abstract] [Full Text] [Related]
37. First trimester noninvasive fetal RHD genotyping using maternal dried blood spots. Xiong Y; Jeronis S; Hoffman B; Liebermann DA; Geifman-Holtzman O Prenat Diagn; 2017 Apr; 37(4):311-317. PubMed ID: 28081297 [TBL] [Abstract][Full Text] [Related]
38. Genotyping approach for non-invasive foetal RHD detection in an admixed population. Boggione CT; Luján Brajovich ME; Mattaloni SM; Di Mónaco RA; García Borrás SE; Biondi CS; Cotorruelo CM Blood Transfus; 2017 Jan; 15(1):66-73. PubMed ID: 27136427 [TBL] [Abstract][Full Text] [Related]
39. Prenatal diagnosis of the fetal RhD blood type using a single fetal nucleated erythrocyte from maternal blood. Sekizawa A; Watanabe A; Kimura T; Saito H; Yanaihara T; Sato T Obstet Gynecol; 1996 Apr; 87(4):501-5. PubMed ID: 8602298 [TBL] [Abstract][Full Text] [Related]
40. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]